Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LEXX
Recent news which mentions LEXX
< Previous
1
2
3
4
Next >
Why Is Lexaria Bioscience (LEXX) Stock Up Today?
April 14, 2022
Tickers
LEXX
Tags
Market News
LEXX
NASDAQ:LEXX
From
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Tickers
BFRI
CLRB
HSTO
ISO
Tags
ISO
VSTM
Market News
From
Benzinga
Why Lexaria Shares Are Rising Today
April 14, 2022
Tickers
LEXX
Tags
LEXX
Biotech
Benzinga
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
April 13, 2022
Tickers
LEXX
LEXXW
Tags
Market News
InvestorBrandNetwork
Biotech
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program
April 12, 2022
Tickers
LEXX
Tags
Market News
InvestorBrandNetwork
Biotech
From
Benzinga
Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research
April 11, 2022
Tickers
LEXX
Tags
LEXX
Market News
Cannabis
From
Benzinga
Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia
March 31, 2022
Tickers
LEXX
Tags
LEXX
Market News
Biotech
From
Benzinga
Lexaria Bioscience Optimistic About Upcoming Hypertension Study
March 28, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Market News
From
Benzinga
Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent
March 22, 2022
Tickers
LEXX
Tags
General
Penny Stocks
Benzinga
From
Benzinga
Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program
March 16, 2022
Tickers
LEXX
LEXXW
Tags
Partner Content
Benzinga
General
From
Benzinga
Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent
March 09, 2022
Tickers
LEXX
Tags
Penny Stocks
General
Partner Content
From
Benzinga
Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs
March 07, 2022
Tickers
LEXX
Tags
Partner Content
Benzinga
Penny Stocks
From
Benzinga
Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil
March 04, 2022
Tickers
LEXX
TM
Tags
Market News
Biotech
InvestorBrandNetwork
From
Benzinga
Lexaria Bioscience Optimistic Of Positive Study Results
February 28, 2022
Tickers
LEXX
Tags
Penny Stocks
Partner Content
Benzinga
From
Benzinga
Lexaria Optimistic About Expanded DehydraTECH Investigations
February 23, 2022
Tickers
LEXX
Tags
LEXX
Biotech
InvestorBrandNetwork
From
Benzinga
Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech
February 22, 2022
Tickers
LEXX
TM
Tags
Penny Stocks
Partner Content
Benzinga
From
Benzinga
Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022
February 17, 2022
Tickers
LEXX
Tags
Partner Content
Benzinga
General
From
Benzinga
Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions
February 14, 2022
Tickers
LEXX
TM
Tags
LEXX
InvestorBrandNetwork
Biotech
From
Benzinga
Lexaria Technology Shows Promise In Improving Performance Of ED Drugs
February 11, 2022
Tickers
LEXX
Tags
Penny Stocks
General
Partner Content
From
Benzinga
Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders
February 09, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Earnings
From
Benzinga
Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study
February 03, 2022
Tickers
LEXX
Tags
Partner Content
Benzinga
General
From
Benzinga
Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast
February 01, 2022
Tickers
LEXX
Tags
LEXX
Biotech
InvestorBrandNetwork
From
Benzinga
Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study
January 28, 2022
Tickers
LEXX
Tags
InvestorBrandNetwork
Cannabis
Markets
From
Benzinga
Lexaria Bioscience Marks Great Start to its 2022 R&D Programs
January 21, 2022
Tickers
LEXX
Tags
General
Benzinga
Partner Content
From
Benzinga
Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2
January 19, 2022
Tickers
LEXX
Tags
Partner Content
Benzinga
Penny Stocks
From
Benzinga
Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine
January 18, 2022
Tickers
LEXX
TM
Tags
General
Penny Stocks
Benzinga
From
Benzinga
Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution
January 12, 2022
Tickers
LEXX
Tags
LEXX
Market News
Cannabis
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study
January 11, 2022
Tickers
LEXX
Tags
Benzinga
Partner Content
News
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Tickers
ATOS
AXSM
CFRX
ENSC
Tags
SXTC
GRPH
PSTV
From
Benzinga
Lexaria Bioscience Increases Investor Visibility with SRAX
January 07, 2022
Tickers
LEXX
SRAX
Tags
Market News
InvestorBrandNetwork
Biotech
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
